Voluntis announces issuance of a European patent for the intelligent patient support in drug dosing with its Theraxium digital therapeutic platform

The patented technology is used to assist patients in optimizing their drug dosage through intelligent and adaptive algorithms. The technology will be applied in the field of diabetes, one of Voluntis’ focus areas, for insulin titration support. Theraxium platform enables clinical and industrial partners to offer unique treatment experiences to patients. It is already being used for drug dosing support in therapeutic areas other than diabetes, particularly in oncology for the dosing of symptomatic treatments.

Access their full press release here